CRL
Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
Charles River Laboratories International, Inc. (CRL) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (A); its weakest is Value (D+).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-16 | D+ (1.8) | C- (2.0) | C+ (2.8) | A (4.2) | B (3.4) | C+ (2.8) |
| 2026-11-09 | D+ (1.8) | C- (2.0) | C+ (2.8) | A (4.2) | B (3.4) | C+ (2.8) |
| 2026-11-06 | C+ (2.7) | C- (2.0) | C+ (2.7) | A+ (4.5) | A+ (4.5) | B (3.3) |
| 2026-11-05 | C+ (2.7) | C- (2.0) | C+ (2.7) | A+ (4.5) | A+ (4.6) | B (3.3) |
| 2026-11-04 | C+ (2.7) | C- (2.0) | C+ (2.7) | A (4.5) | A (4.3) | B (3.2) |